These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7196228)

  • 1. Inhibition of human platelet thromboxane synthetase by 11a-carbathromboxane A2 analogs.
    Gorman RR; Maxey KM; Bundy GL
    Biochem Biophys Res Commun; 1981 May; 100(1):184-90. PubMed ID: 7196228
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis and biological properties of pinane-thromboxane A2, a selective inhibitor of coronary artery constriction, platelet aggregation, and thromboxane formation.
    Nicolaou KC; Magolda RL; Smith JB; Aharony D; Smith EF; Lefer AM
    Proc Natl Acad Sci U S A; 1979 Jun; 76(6):2566-70. PubMed ID: 288046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 7-Oxabicyclo[2.2.1]heptane analogs as modulators of the thromboxane A2 and prostacyclin receptors.
    Sprague PW; Heikes JE; Harris DN; Greenberg R
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():337-43. PubMed ID: 6303073
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacological studies on OKY-1581: a selective thromboxane synthetase inhibitor.
    Hiraku S; Wakitani K; Katsube N; Kawasaki A; Tsuboshima M; Naito J; Ujiie A; Komatsu H; Iizuka K
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():241-4. PubMed ID: 6221530
    [No Abstract]   [Full Text] [Related]  

  • 5. Biology and biochemistry of thromboxane synthetase inhibitors.
    Gorman RR
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():235-40. PubMed ID: 6221529
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of arachidonate metabolism by selected compounds in vitro with particular emphasis on the thromboxane A2 synthase pathway.
    Tobias LD; Hamilton JG
    Adv Prostaglandin Thromboxane Res; 1980; 6():453-6. PubMed ID: 6770605
    [No Abstract]   [Full Text] [Related]  

  • 7. Stereocontrolled synthesis of 7-oxabicyclo (2.2.1) heptane prostaglandin analogs as thromboxane A2 antagonists.
    Sprague PW; Heikes JE; Harris DN; Greenberg R
    Adv Prostaglandin Thromboxane Res; 1980; 6():493-6. PubMed ID: 7189952
    [No Abstract]   [Full Text] [Related]  

  • 8. Biological effects of 15-hydroperoxythromboxane A2 on platelets and aorta.
    Hammarström S
    Prostaglandins Med; 1980 May; 4(5):297-302. PubMed ID: 7403329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thromboxane A2-induced vascular endothelial cell damage and respiratory smooth muscle cell contraction: inhibition by flunarizine, a Ca2+-overload blocker.
    De Clerck F; Loots W; Somers Y; Van Gorp L; Verheyen A; Wouters L
    Arch Int Pharmacodyn Ther; 1985 Mar; 274(1):4-23. PubMed ID: 2990365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thromboxane synthetase inhibitors differentially antagonize thromboxane receptors in vascular smooth muscle.
    Smith EF; Lefer AM; Smith JB; Nicolaou KC
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Dec; 318(2):130-4. PubMed ID: 6276789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imidazo[1,5-a]pyridines: a new class of thromboxane A2 synthetase inhibitors.
    Ford NF; Browne LJ; Campbell T; Gemenden C; Goldstein R; Gude C; Wasley JW
    J Med Chem; 1985 Feb; 28(2):164-70. PubMed ID: 3918169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syntheses of thromboxane A2 analogs: Thia- and dithiathromboxane A2.
    Hamanaka N; Ohuchida S; Hayashi M
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():319-22. PubMed ID: 6221543
    [No Abstract]   [Full Text] [Related]  

  • 13. 9,11-Iminoepoxyprosta-5,13-dienoic acid is a selective thromboxane A2 synthetase inhibitor.
    Fitzpatrick F; Gorman R; Bundy G; Honohan T; McGuire J; Sun F
    Biochim Biophys Acta; 1979 May; 573(2):238-44. PubMed ID: 375987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A structural analog of thromboxane A2.
    Ansell MF; Caton MP; Palfreyman MN; Stuttle KA; Tuffin D; Walker JL
    Adv Prostaglandin Thromboxane Res; 1980; 6():485-7. PubMed ID: 7386282
    [No Abstract]   [Full Text] [Related]  

  • 15. Selective inhibition of thromboxane synthetase by pyridine and its derivatives.
    Tai HH; Tai CL; Lee N
    Arch Biochem Biophys; 1980 Sep; 203(2):758-63. PubMed ID: 7192966
    [No Abstract]   [Full Text] [Related]  

  • 16. Reciprocal regulation of human platelet cAMP levels by thromboxane A2 and prostacyclin.
    Gorman RR; Fitzpatrick FA; Miller OV
    Adv Cyclic Nucleotide Res; 1978; 9():597-609. PubMed ID: 208399
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
    Yu SM; Wu TS; Teng CM
    Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboxane A2: effects on airway and vascular smooth muscle.
    Svenssen J; Strandberg K; Tuvemo T; Hamberg M
    Prostaglandins; 1977 Sep; 14(3):425-36. PubMed ID: 905570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further studies on the effects of epimers of thromboxane A2 antagonists on platelets and veins.
    Mais DE; Dunlap C; Hamanaka N; Halushka PV
    Eur J Pharmacol; 1985 Apr; 111(1):125-8. PubMed ID: 4018122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of thromboxane synthesis and platelet aggregation by pyridine and its derivatives.
    Tai HH; Lee N; Tai CL
    Adv Prostaglandin Thromboxane Res; 1980; 6():447-52. PubMed ID: 7189951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.